<DOC>
	<DOCNO>NCT01964443</DOCNO>
	<brief_summary>The purpose study explore impact plaque psoriasis different dimension patient life include psychological disorder , different type addiction , consequence health-related quality life socioeconomic parameter baseline ( cross-sectional part ) initial year psoriasis disease ( longitudinal part ) .</brief_summary>
	<brief_title>Clinical Assessment Psychosocial Impact Psoriasis</brief_title>
	<detailed_description>This prospective , non-interventional , observational , multicenter study document prevalence alexithymia adult men woman , 18 year age old , onset first symptoms plaque psoriasis le 10 year study entry , naïve experienced topical treatment , eligible phototherapy systemic treatment . Only data available routine clinical practice collect treatment decision make discretion treat physician . Additionally , local regulation permit , participate physician ask obtain Patient-Reported Outcome ( PRO ) data patient participate observational study . A target 800 adult patient participate study approximately 80 site . The enrollment period study expect continue approximately 9 month . Each patient receive treatment per standard clinical practice follow 12 month . Therefore , total duration observational study expect approximately 21 month . Overall psoriasis disease severity assess physician document baseline ( cross-sectional ) observational ( longitudinal ) phase study . Several outcome relate psychosocial comorbidities ( eg , alexithymia , anxiety , depression ) , addiction , work activity impairment measure PRO questionnaire scale also collect . Information psoriasis treatment ( ) ( topical , phototherapy , systemic [ non-biologic , biologic ] ) , mental health drug ( include use sleep ) , concomitant medication give comorbid medical condition also collect . The data study analyze report separately cross-sectional data ( baseline ) longitudinal data ( baseline Month 12 ) .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Have onset first symptoms plaque psoriasis le 10 year baseline ; Be either naïve experienced topical treatment ; Be eligible phototherapy systemic treatment , determine participate physician patient 's baseline visit . Has history current treatment systemic agent ( include biologic agent ) ; Has nonplaque form psoriasis ( eg , erythrodermic , guttate , pustular ) ; Has receive investigational drug ( include investigational vaccine ) use invasive investigational medical device within 30 day start study first data collection time point .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Plaque Psoriasis</keyword>
	<keyword>Alexithymia</keyword>
	<keyword>Quality life</keyword>
</DOC>